Kodiak Sciences Inc (KOD) carries a Roarable Rating of C (Hold) with 62/100 RQD Confidence. The underlying business is intact, so current owners don’t need to panic-sell—but mixed big-money flow or rich pricing means new buyers can afford to wait for either a pullback or a B-or-higher upgrade.
Kodiak Sciences Inc (KOD) surged +3.46% to $100.40 as options desks priced 58% call premium vs. 42% put protection around the $98 max-pain magnet. Solid 41% profit margin (-35% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.
This whale alert can help traders discover the next big trading opportunities. Whales are entities with large sums of money and we track their transactions here at Benzinga on our options activity scanner. Traders often
-SEC Filing
Kodiak's Zenkuda shows promise across three retinal diseases, with positive phase III data and a planned 2026 regulatory filing.
Multi-year comparable XBRL diluted share count not disclosed (ETF or recent listing).
vs. +1.1% actual YoY revenue growth (assuming 9.25% cost of equity & 16.5x terminal multiple).
No active Ellis Vennor swing setup published on KOD today. View full Setup Ledger →
No direct multi-tier Butterfly edges indexed yet for KOD. Explore sector supply chains on /butterfly.
Why KOD Stock surged +3.46% Today — RQD Quant Desk Flash. Solid 41% profit margin (-35% return on capital), mixed timing at current multiples—hold if owned, no rush to chase.